Last reviewed · How we verify
No Hyperbaric Oxygen
This is a negative control or sham intervention study comparing the absence of hyperbaric oxygen therapy to standard care.
This is a negative control or sham intervention study comparing the absence of hyperbaric oxygen therapy to standard care. Used for Control arm in a clinical trial (specific indication unknown).
At a glance
| Generic name | No Hyperbaric Oxygen |
|---|---|
| Also known as | Hyperbaric Oxygen Therapy |
| Sponsor | Louisiana State University Health Sciences Center in New Orleans |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Hyperbaric oxygen therapy involves exposing patients to increased atmospheric pressure in an oxygen-enriched environment. This study arm represents the control group receiving no such intervention, allowing researchers to evaluate the efficacy of hyperbaric oxygen by comparison. The mechanism being tested is whether elevated oxygen pressure has therapeutic benefit beyond standard treatment.
Approved indications
- Control arm in a clinical trial (specific indication unknown)
Common side effects
Key clinical trials
- The Effect of Nitrogen Narcosis on Motor Performance in Divers Who Have Sustained an Inner Ear Decompression Illness
- Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers
- Effect of HBOT on Femoral Head Avascular Necrosis (AVN) (NA)
- Effect of Sedation After Ultrasound-Guided Spinal Anesthesia on Back Pain (NA)
- Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy (PHASE1, PHASE2)
- Hyperbaric Oxygen Brain Injury Treatment Trial (PHASE2)
- Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible (PHASE3)
- Necrotizing Soft Tissue Infections
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: